NACDS: House Oversight Hearing Fuels PBM Reform’s “Must-Pass” Status
NACDS urges “tenacity” by House Oversight and Accountability Committee in its hearing and investigation.
NACDS urges “tenacity” by House Oversight and Accountability Committee in its hearing and investigation.
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S. House Committee on Oversight and Accountability hearing on PBM middlemen tactics.
Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
NACDS President and CEO Steven C. Anderson relayed recommendations in a statement for the record of the U.S. Senate Finance Committee’s hearing today on “Rural Healthcare: Supporting Lives and Improving Communities.”
NACDS urges “PBM Reform Now” on a full array of bipartisan reforms advanced by key Congressional committees.
NACDS is urging lawmakers, HHS, CMS and other stakeholders to take action to help ensure affordable, high-quality and uninterrupted access to healthcare for Americans – including swift enactment of PBM reforms in Medicaid and Medicare.
NACDS.org caught up this week with past NACDS Chair Colleen Lindholz, president of Kroger Health, The Kroger Co., to discuss the company’s outstanding engagement in myriad NACDS RxIMPACT grassroots programs, including the recent March fly-in event on Capitol Hill.
Centers for Disease Control and Prevention study reveals new data related to Federal Retail Pharmacy Program contributions to bivalent mRNA COVID-19 vaccinations; underscores scalability of pharmacy-based services for future public health emergencies.
Watch the newly released one-minute summary of NACDS’ March 14 press conference to support the enactment of federal PBM reform legislation, without delay.